A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia
A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia have?
A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia has 6 citations in the OpenAlex counts ScholarIQ stores.
When was A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia published?
A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia has 2023 year in the ScholarIQ index.
What is the open-access status of A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia?
A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia has diamond oa status in the ScholarIQ index.
What is the DOI of A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia?
The DOI for A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia is on the source record.
What is the PMID of A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia?
The PMID for A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia is on the source record.
What is the OpenAlex record for A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia?
The OpenAlex for A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia is on the source record.